Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for PsychosisCassandra M.J. WannanBarnaby Nelsonet al.2024Schizophrenia Bulletin
Baseline reward processing and ventrostriatal dopamine function are associated with pramipexole response in depressionAlexis E. WhittonJenna M. Reinenet al.2020Brain
Fusion of biomedical imaging studies for increased sample size and diversity: a case study of brain MRIMatias AiskovichEduardo Castroet al.2024Frontiers in Radiology
PainPoints: A Framework for Language-based Detection of Chronic Pain and Expert-Collaborative Text-SummarizationShreyas FadnavisAmit Dhurandharet al.2022ML4H 2022
Differential reinforcement learning responses to positive and negative information in unmedicated individuals with depressionJenna M. ReinenAlexis E. Whittonet al.2021European Neuropsychopharmacology
Identifying neural signatures mediating behavioral symptoms and psychosis onset: High-dimensional whole brain functional mediation analysisOliver Y. ChénHengyi Caoet al.2021NeuroImage